Detection of β-Thalassemia Mutations Using a Multiplex Amplification Refractory Mutation System Assay

Hemoglobin ◽  
2008 ◽  
Vol 32 (4) ◽  
pp. 403-409 ◽  
Author(s):  
Saisiri Mirasena ◽  
Dawan Shimbhu ◽  
Mondhon Sanguansermsri ◽  
Torpong Sanguansermsri
VirusDisease ◽  
2018 ◽  
Vol 29 (4) ◽  
pp. 565-568 ◽  
Author(s):  
Vikas Gupta ◽  
Vishal Chander ◽  
Soumendu Chakravarti ◽  
Gaurav Kumar Sharma ◽  
Javed Ahmed Malla ◽  
...  

2016 ◽  
Vol 46 ◽  
pp. 59-64 ◽  
Author(s):  
Vishal Chander ◽  
Soumendu Chakravarti ◽  
Vikas Gupta ◽  
Sukdeb Nandi ◽  
Mithilesh Singh ◽  
...  

2017 ◽  
Vol 25 (2) ◽  
pp. 321-332
Author(s):  
D. Shimbhu ◽  
S. Mirasena ◽  
M. Sanguansermsri ◽  
T. Sanguansermsri

The number of mutations underlining b-thalassemia generate a wide variety of different clinical phenotypes. An understanding of the genotype is important for medical personnel in order to provide proper counseling to patients and their families. Characterization of these mutations should aid the planning of a prenatal diagnosis program for bthalassemia. The heterogeneity of the mutations makes it difficult and time consuming to identify the mutation in some individuals. We developed a single-tube multiplex amplification refractory mutation system (multiplex ARMS) to identify common ethnic- specific b-thalassemia mutations. Confirmation of multiplex ARMS results was carried out using direct sequencing. Three thousand three hundred twenty two people from Phitsanulok province were screened for the b-thalassemia trait by quantitation of HbA2 with microcolumn chromatography and the genotypes of mutations were characterized using multiplex ARMS and direct sequencing. We found that the deletion at codons 41/42 (-TCTT) was the most frequent (48%), codon 17 (A®T) (30%), -28 (A®G) (6%) and IVS-I-1(G®T) (6%) were the second and third in frequency respectively. A -87 (C®A) mutation (4%), IVS II-654 (C®T) (2%), codons 71/72 (+A) (2%) and codon 35 (C®A) mutations (2%) were also found. These techniques were found to be a valuable tool for analysis of b-thalassemia mutations because they are accurate, simple, and speedy in operation. The application for the diagnosis of severe thalassemia in high-risk pregnancies is promising.    


2018 ◽  
Vol 38 (4) ◽  
pp. 378-380 ◽  
Author(s):  
Akiyo Nakano ◽  
Ryuichi Nakano ◽  
Yuki Suzuki ◽  
Kyoichi Saito ◽  
Kei Kasahara ◽  
...  

2014 ◽  
Vol 26 (6) ◽  
pp. 721-733 ◽  
Author(s):  
Shr-Wei Huang ◽  
Chia-Fang Ho ◽  
Kun-Wei Chan ◽  
Min-Chung Cheng ◽  
Jui-Hung Shien ◽  
...  

Infectious bronchitis virus (IBV; Avian coronavirus) causes acute respiratory and reproductive and urogenital diseases in chickens. Following sequence alignment of IBV strains, a combination of selective primer sets was designed to individually amplify the IBV wild-type and vaccine strains using a multiplex amplification refractory mutation system reverse transcription polymerase chain reaction (ARMS RT-PCR) approach. This system was shown to discriminate the IBV wild-type and vaccine strains. Moreover, an ARMS real-time RT-PCR (ARMS qRT-PCR) was combined with a high-resolution analysis (HRMA) to establish a melt curve analysis program. The specificity of the ARMS RT-PCR and the ARMS qRT-PCR was verified using unrelated avian viruses. Different melting temperatures and distinct normalized and shifted melting curve patterns for the IBV Mass, IBV H120, IBV TW-I, and IBV TW-II strains were detected. The new assays were used on samples of lung and trachea as well as virus from allantoic fluid and cell culture. In addition to being able to detect the presence of IBV vaccine and wild-type strains by ARMS RT-PCR, the IBV Mass, IBV H120, IBV TW-I, and IBV TW-II strains were distinguished using ARMS qRT-PCR by their melting temperatures and by HRMA. These approaches have acceptable sensitivities and specificities and therefore should be able to serve as options when carrying out differential diagnosis of IBV in Taiwan and China.


Sign in / Sign up

Export Citation Format

Share Document